These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 31372221
1. Hyaluronic Acid Grafted Nanoparticles of a Platinum(II)-Silicon(IV) Phthalocyanine Conjugate for Tumor and Mitochondria-Targeted Photodynamic Therapy in Red Light. Mitra K, Samso M, Lyons CE, Hartman MCT. J Mater Chem B; 2018 Dec 07; 6(45):7373-7377. PubMed ID: 31372221 [Abstract] [Full Text] [Related]
2. Monomer zinc phthalocyanine/upconversion nanoparticle coated with hyaluronic acid crosslinked gel as NIR light-activated drug for in vitro photodynamic therapy. Zhou L, Chen E, Jin W, Wang Y, Zhou J, Wei S. Dalton Trans; 2016 Sep 27; 45(38):15170-15179. PubMed ID: 27711660 [Abstract] [Full Text] [Related]
3. Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment. Huang Y, Liu G, Zheng F, Chen J, Lin Y, Wang J, Huang Y, Peng Y. Colloids Surf B Biointerfaces; 2024 Jun 27; 238():113890. PubMed ID: 38608462 [Abstract] [Full Text] [Related]
4. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy. Li K, Qiu L, Liu Q, Lv G, Zhao X, Wang S, Lin J. J Photochem Photobiol B; 2017 Sep 27; 174():243-250. PubMed ID: 28802175 [Abstract] [Full Text] [Related]
7. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy. Sun CY, Zhang BB, Zhou JY. J Mater Chem B; 2019 Aug 07; 7(31):4843-4853. PubMed ID: 31389968 [Abstract] [Full Text] [Related]